BOSTON (WBZ NewsRadio) — The work of Dr. Jennifer Doudna has lead to new crops, and aims to eventually cure inherited diseases like cancer.
On Wednesday, Dr. Doudna and Dr. Emmanuelle Charpentier were the first women to jointly win the 2020 Nobel Prize for Chemistry for their work developing the CRISPR–Cas9 gene-editing tools.
Dr. Doudna earned her PhD from Harvard Medical School in 1989 in Biological Chemistry and Molecular Pharmacology.
Ahead of the Nobel Committee's announcement, Dr. Doudna told reporters she is currently working on a project to develop a saliva test for COVID-19.
"A key question right now is will saliva be as good a matrix for testing as nasal swabs," she said.
WBZ NewsRadio's Drew Moholland reports:
Follow WBZ NewsRadio: Facebook | Twitter | Instagram | iHeartmedia App
(Photo: Getty Images)